| Nedocromil sodium 2% ophthalmic solution (Tilavist(TM)) A new topical treatment for ocular allergic inflammation. | |
| | |
MedLine Citation:
|
PMID: 22827188 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Nedocromil sodium, a non-toxic pyranoquinoline dicarboxylate, was developed as a novel topical treatment for allergic inflammatory lung diseases. With a broader pharmacological potential than the chromone compound sodium cromoglycate, nedocromil sodium has more potent antiinflammatory effects whilst maintaining a good safety profile due to rapid excretion, unmetabolized. Having the ability to stabilize both mucosal (MC(T)) and connective tissue (MC(TC)) mast cells and directly to inhibit activated cells such as eosinophils, which are involved in continuing allergic inflammation in the eye as well as in the airways, nedocromil sodium appears ideally suited to the treatment of allergic conjunctivitis. Preliminary therapeutic trials have confirmed efficacy and the lack of side-effects of the 2% eye drop formulation of nedocromil sodium, and its comparative potency which permits twice-daily administration for seasonal ocular symptoms, with the safe option of increasing to four times daily use for more severe, chronic allergic inflammatory conditions. With many patients already symptomatic at the start of trial treatment, nedocromil sodium eye drops have also proved to have a rapid onset of action providing relief of symptoms in 24 hours in the majority of cases, and often within one hour of the first dose. |
| | |
Authors:
|
I G Knottnerus; C N Scott; P A Riley |
Related Documents
:
|
6837688 - Effect of timolol on aqueous humor protein concentration in humans. 110028 - Dscg eye drops in allergic rhino-conjunctivitis. 22701848 - Metformin and sleep disorders. 21532518 - Comparisons of nerve fiber layer thickness measurements between stratus, cirrus, and rt... 17235538 - Air movement preferences observed in office buildings. 15082158 - Nocturnal urinary dopamine excretion is reduced in otherwise healthy subjects with peri... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Ocular immunology and inflammation Volume: 1 ISSN: 0927-3948 ISO Abbreviation: Ocul. Immunol. Inflamm. Publication Date: 1993 |
Date Detail:
|
Created Date: 2012-07-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9312169 Medline TA: Ocul Immunol Inflamm Country: England |
Other Details:
|
Languages: eng Pagination: 27-30 Citation Subset: - |
Affiliation:
|
Fisons plc Pharmaceutical Division, Loughborough LEII OBB, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Studies comparing the efficacy of nedocromil sodium eye drops with sodium cromoglycate and placebo i...
Next Document: Nedocromil sodium and astemizole, alone or combined, for treatment of seasonal allergic conjunctivit...